re: forrestgump / ridge G'day Shelly,As far as the commercial...

re: forrestgump / ridge G'day Shelly,

As far as the commercial arrangements go, CST have elected not to licence out the technology but to sell the test kits themselves. In Australia and USA they are doing this directly, in all other countries, including Japan, they have appointed resellers.

There are licence fees that are paid to CSL and Statens (SSI), as shown in the spreadsheet.

Currently, the kit itself is produced by CSL for CST. There has been some talk of setting up their own manufacturing facility but nothing definate one way or the other.

There are currently about 1.5m unlisted options held by the directors and employees with exercise prices of between .25 and 1.38. There are no other options. The company did a small capital raising by issuing some shares to a fund (portfolio partners). They currently have a bit over $6m cash and are unlikely to need additional capital before becoming cashflow +ve.

Hope this helps